CDT Equity Inc.

CDT Healthcare Biotechnology

In the quarter to June 2026, EPS grew 98.0% and free cash flow grew 78.9%, each against the same quarter a year earlier.

0.24 0.03 +14.29%
Market cap
$240.0K
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Current Ratio

+8 more quarters

1.66 0.34 0.14 0.13
Net Debt/EBITDA
0.67 0.07 0.03 0.34
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(54,030.00) (40,460.00) (653.10) (25.54)
Book value per Share
42,780.00 (71,700.00) 36,362.41 4,840.05
Free Cash Flow
(5.40) (4.05) (1.89) (0.54)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Oct 2026